Scientists identified a 'statistically significant' association between using a specific hand and certain learning ...

Dyslexia is a common learning difficulty that can cause problems with reading, writing, and spelling. The NHS describes it as ...

A new study has found a 'statistically significant' links between the hand you write with and certain language-related ...

On Wednesday, following controversy about inconsistencies in her résumé, President Trump withdrew his nomination of Dr.

Monroe even made a joke that she knew her daughter's hand would probably be hurting at the end of the day from all that writing. Monroe's daughter didn't get the humor, however. She asked her mom ...

A schizophrenic mother who killed her son with a handsaw after hearing 'demonic voices' has been handed an indefinite hospital order. Alexander Zurawski, six, died of horrific injuries at the ...

On the heels of a clinical setback for Bristol Myers Squibb’s schizophrenia newcomer Cobenfy, the New Jersey pharma is serving up mixed results for the first three months of the year.

Like all other effects, you need a base, and for the Schizophrenic effect, the one we will go with is OG Kush, as it is cheaper than the rest of the weed strains. Place the OG Kush in your mixer ...

A new, closely watched schizophrenia medication from Bristol Myers Squibb sold well in its first full quarter on the market, according to both the company and analysts. In its latest earnings report, ...

A Bristol Myers Squibb drug whose landmark FDA approval introduced the first novel mechanism for treating schizophrenia in decades has failed a pivotal test intended to support expanding its use ...

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of exclusivity, has hit a phase 3 setback. Cobenfy as an adjunctive ...

Preliminary analyses suggest that Cobenfy as an adjunctive treatment to an atypical antipsychotic was associated with improvements in symptoms of schizophrenia compared to placebo plus an atypical ...